Restriction on Export of Remdesivir Injection and API removed

The export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API), Amphotericin – B injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under HS code as mentioned above or falling under any other HS code has been made ‘Free’ with immediate effect.

MINISTRY OF COMMERCE AND INDUSTRY
(Department of Commerce)
(DIRECTORATE GENERAL OF FOREIGN TRADE)
New Delhi, the 24^th February, 2022

Notification No. 56/2015-2020-DGFT

Subject: Amendment in Export Policy of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) – regarding

S.O. 846(E).—In exercise of powers conferred by Section 3 read with Section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes following amendment in Notification No. 08/2015-20 dated 14.06.2021, Notification No. 07/2015-20 dated 01.06.2021 and Notification No. 50/2015-20 dated 10.01.2022 related to export of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API):

2. Effect of this Notification:

The export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API), Amphotericin – B injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under HS code as mentioned above or falling under any other HS code has been made ‘Free’ with immediate effect.

[F. No. 01/91/180/24/AM22/EC /E-27724]
SANTOSH KUMAR SARANGI, Director General of Foreign Trade
& Ex-Officio Addl. Secy.